| scholarly article | Q13442814 |
| P356 | DOI | 10.1183/09031936.00022011 |
| P698 | PubMed publication ID | 21920897 |
| P50 | author | Lisa Wood | Q41584382 |
| Maria B. Sukkar | Q42514257 | ||
| Peter Wark | Q42642823 | ||
| Peter G Gibson | Q61163991 | ||
| P2093 | author name string | J L Simpson | |
| V M McDonald | |||
| M Tooze | |||
| P433 | issue | 3 | |
| P921 | main subject | asthma | Q35869 |
| chronic obstructive pulmonary disease | Q199804 | ||
| P304 | page(s) | 721-729 | |
| P577 | publication date | 2011-09-15 | |
| P1433 | published in | European Respiratory Journal | Q12257435 |
| P1476 | title | Soluble RAGE is deficient in neutrophilic asthma and COPD | |
| P478 | volume | 39 |
| Q37205073 | A Systemic Inflammatory Endotype of Asthma With More Severe Disease Identified by Unbiased Clustering of the Serum Cytokine Profile |
| Q88072187 | ATP/P2X7-NLRP3 axis of dendritic cells participates in the regulation of airway inflammation and hyper-responsiveness in asthma by mediating HMGB1 expression and secretion |
| Q33801198 | Association between HMGB1 and asthma: a literature review |
| Q92375723 | Association of RAGE gene multiple variants with the risk for COPD and asthma in northern Han Chinese |
| Q37620204 | Association of plasma sRAGE, but not esRAGE with lung function impairment in COPD. |
| Q37667568 | Association of polymorphisms of the receptor for advanced glycation end products gene with COPD in the Chinese population |
| Q35064231 | Associations between maternal and infant morbidities and sRAGE within the first week of life in extremely preterm infants |
| Q26782718 | Biomarkers and severe asthma: a critical appraisal |
| Q26766294 | Challenges and Current Efforts in the Development of Biomarkers for Chronic Inflammatory and Remodeling Conditions of the Lungs |
| Q38154796 | DAMPs activating innate and adaptive immune responses in COPD. |
| Q94463922 | Decreased Soluble Receptor of Advanced Glycation End Product Levels Correlated with Inflammation in Silicosis |
| Q33684145 | Emerging role of HMGB1 in lung diseases: friend or foe. |
| Q34622835 | HMGB1 in health and disease |
| Q36081780 | HMGB1/RAGE Signaling and Pro-Inflammatory Cytokine Responses in Non-HIV Adults with Active Pulmonary Tuberculosis. |
| Q37057836 | Inflammation and immune response in COPD: where do we stand? |
| Q34447539 | Innate immunity but not NLRP3 inflammasome activation correlates with severity of stable COPD. |
| Q50073081 | Inverse Relationship Between Soluble RAGE and Risk for Bronchopulmonary Dysplasia. |
| Q89964070 | Kaempferol Improves Lung Ischemia-Reperfusion Injury via Antiinflammation and Antioxidative Stress Regulated by SIRT1/HMGB1/NF-κB Axis |
| Q38756064 | Novel approaches to the management of noneosinophilic asthma |
| Q53066000 | Overexpression of RAGE contributes to cigarette smoke-induced nitric oxide generation in COPD. |
| Q36633619 | Plasma sRAGE enables prediction of acute lung injury after cardiac surgery in children |
| Q38154291 | Pulmonary biomarkers in COPD exacerbations: a systematic review |
| Q61446621 | RAGE is a Critical Mediator of Pulmonary Oxidative Stress, Alveolar Macrophage Activation and Emphysema in Response to Cigarette Smoke |
| Q27025295 | RAGE: a new frontier in chronic airways disease |
| Q21285070 | Receptor for advanced glycation end products and its involvement in inflammatory diseases |
| Q41571383 | Receptor for advanced glycation end-products and World Trade Center particulate induced lung function loss: a case-cohort study and murine model of acute particulate exposure |
| Q62731127 | Receptor for advanced glycation end-products and environmental exposure related obstructive airways disease: a systematic review |
| Q33756371 | Receptor for advanced glycation end-products regulates lung fluid balance via protein kinase C-gp91(phox) signaling to epithelial sodium channels |
| Q33873927 | Receptor for advanced glycation endproducts (RAGE) maintains pulmonary structure and regulates the response to cigarette smoke |
| Q40659883 | S100A12 and the Airway Smooth Muscle: Beyond Inflammation and Constriction |
| Q28387007 | S100A12 is up-regulated in pulmonary tuberculosis and predicts the extent of alveolar infiltration on chest radiography: an observational study |
| Q92428765 | Six gene and TH2 signature expression in endobronchial biopsies of participants with asthma |
| Q33613288 | Soluble receptor for advanced glycation end-products and progression of airway disease |
| Q28728578 | Systemic biomarkers of neutrophilic inflammation, tissue injury and repair in COPD patients with differing levels of disease severity |
| Q85239968 | Systemic levels of the anti-inflammatory decoy receptor soluble RAGE (receptor for advanced glycation end products) are decreased in dogs with inflammatory bowel disease |
| Q92315405 | The Modern Western Diet Rich in Advanced Glycation End-Products (AGEs): An Overview of Its Impact on Obesity and Early Progression of Renal Pathology |
| Q36670537 | The molecular basis of peanut allergy |
| Q36177340 | The predictors of poorly controlled asthma in elderly |
| Q42044686 | The receptor for advanced glycation end products is a central mediator of asthma pathogenesis |
| Q60048939 | The usefulness of soluble receptor for advanced glycation end-products in the identification of COPD frequent exacerbator phenotype |
| Q47133236 | sRAGE alleviates neutrophilic asthma by blocking HMGB1/RAGE signalling in airway dendritic cells |
Search more.